Cann Group Email Format
Pharmaceutical ManufacturingVictoria, Australia51-200 Employees
Cann Group operates across the medicinal cannabis value chain, from breeding and cultivation to manufacturing and supply, serving Australia and select export markets. It maintains research, cultivation and GMP-compliant facilities in Bundoora, a northern part of Melbourne, as well as a large-scale cultivation and manufacturing site near Mildura in regional Victoria. The company emphasizes expertise in plant genetics, breeding, extraction, analysis and production methods to deliver medicines that are high quality and safe for a range of medical conditions. Its brand portfolio includes a proprietary cannabinoid delivery system named Satipharm and Botanitech, a line of diverse products. The first stage of its new regional Victoria facility is operational, with in-house analytical labs, and capacity to produce up to 12,500 kilograms of high-quality cannabis flower annually.